Trial NCT05456269

View at ClinicalTrials.gov 
Org. Study IDs: RAC-006

Last trial update was posted on 2023-10-03

MeSH Interventions

Bisantrene Cytarabine Decitabine Decitabine and cedazuridine drug combination

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute Leukemia, Myelomonocytic, Chronic Leukemia, Myelomonocytic, Juvenile Myelodysplastic Syndromes

Other Conditions

Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Higher Risk Myelodysplastic Syndrome Recurrent Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia

Stopping Reasons

commercial reason

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID